NEOGENOMICS INC 4

4 · NEOGENOMICS INC · Filed May 20, 2016

Form 4

Period: 2016-05-18

CIO

Transactions

Exercise/Conversion
Common Stock
2016-05-18$4.78/sh+18,000$86,040→ 22,500 total
Sale
Common Stock
2016-05-18$8.50/sh−18,000$153,000→ 4,500 total
Exercise of In-Money
Stock Option (Right to buy)
2016-05-18$4.78/sh−18,000$86,040→ 67,000 total
Exercise: $4.78From: 2016-05-06Exp: 2020-05-06→ Common Stock (18,000 underlying)

Holdings

Common Stock
4,500
Stock option (Right to buy)
Exercise: $7.15From: 2017-04-20Exp: 2021-04-20→ Common Stock (40,000 underlying)
40,000
Stock Option (Right to buy)
Exercise: $3.93From: 2014-04-22Exp: 2018-04-22→ Common Stock (37,500 underlying)
37,500

Footnotes (3)

[F1]On April 20, 2016, Mr. Ross was granted 40,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.
[F2]On April 22, 2013, Mr. Ross was granted 150,000 options to purchase common stock of the Company. These options vest ratably on each of the next four anniversary dates of the grant date. On April 29, 2016, Mr. Ross exercised 112,500 of these options leaving a balance of 37,500.
[F3]On May 6, 2015, Mr. Ross was granted 100,000 stock options to purchase common stock of the Company. These options vest ratably on each of the first three anniversary dates of the grant date. On May 9, 2016, Mr. Ross exercised 15,000 of these options and on May 18, 2016 Mr. Ross exercised 18,000 options leaving a balance of 67,000 options.

Documents

1 file